Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02211430 · ClinicalTrials.gov registry record · NA
Smoking Cessation for Low-Income Pregnant Women
A NA study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 277
- Enrollment target
NCT02211430 is a NA study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 277 participants.
The verdict
NCT02211430, a NA study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 277 participants
- Enrollment target
Study Summary
To meet the Healthy People 2010 objective of increasing tobacco abstinence among pregnant women to 90%, new methods for treating nicotine addiction among pregnant women are needed. To this end, we propose to evaluate an innovative cognitive-behavioral smoking cessation intervention for low-income, minority women conducted in the prenatal and postpartum phases. Considering the strong link between tobacco use and cancer risk, the development of effective smoking cessation treatments has important health implications for cancer prevention and control initiatives. The aims to be addressed are: Aim 1: To compare an enhanced Cognitive-Behavioral Counseling (CBC) smoking cessation intervention with a Best Practice control condition (BP) for reducing smoking rates (i.e., continued abstinence, 7-day point prevalence, and number of cigarettes smoked) in the short- and long-term among pregnant women. It is hypothesized that smokers receiving CBC will show reduced rates of tobacco use, versus those in the BP, over time. Aim 2: To evaluate the impact of the CBC intervention on the hypothesized mediators of behavior change (i.e., heightened risk perceptions; enhanced self-efficacy and reduced fatalistic beliefs; high pros and low cons of quitting; reduced emotional distress). It is hypothesized that the psychosocial factors will mediate the effect of the CBC intervention on change of smoking behaviors.
Interventions
- BEHAVIORAL Cognitive-Behavioral Counseling (CBC)
- BEHAVIORAL Best Practice (BC) Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2002-10 |
| Est. Completion | 2007-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02211430
The ClinicalTrials.gov registry entry for NCT02211430 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 277 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive-Behavioral Counseling (CBC) is the first listed.
NCT02211430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02211430 about?
NCT02211430 is a clinical study titled "Smoking Cessation for Low-Income Pregnant Women". To meet the Healthy People 2010 objective of increasing tobacco abstinence among pregnant women to 90%, new methods for treating nicotine addiction among pregnant women are needed. To this end, we propose to evaluate an innovative cognitive-behavioral smoking cessation intervention for low-income, m...
What is the current status of trial NCT02211430?
This trial is currently completed. It is a NA study. The enrollment target is 277 participants. The study started on 2002-10. Estimated completion is 2007-03.
What interventions are being tested in trial NCT02211430?
The interventions under investigation include: Cognitive-Behavioral Counseling (CBC) (BEHAVIORAL), Best Practice (BC) Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT02211430?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.